Viewbix Inc. announced that its wholly‑owned subsidiary Quantum X Labs filed a provisional U.S. patent application (No. 64/000,184) on March 9, 2026 for a novel nuclear‑magnetic‑resonance gyroscope architecture that promises ultra‑high precision rotational sensing at a lower cost than existing optical or mechanical gyroscopes. The filing is part of the company’s broader quantum‑technology pivot aimed at replacing GPS‑dependent navigation systems.
The patent application follows a license agreement signed earlier in the year with Quantum Gyro Ltd., a minority‑owned subsidiary of Viewbix. Under the agreement, Quantum Gyro will develop and commercialize the technology once the patent is granted, and Taurus Gold Corp., the controlling shareholder of Quantum Gyro, fulfilled its $200,000 investment commitment in a private placement that closed on March 4, 2026.
Viewbix’s advertising business remains distressed, with trailing twelve‑month revenue of $11.1 million as of September 30 2025. The new NMR gyroscope technology targets aerospace, maritime, robotics, and defense markets, offering a lower‑cost alternative to optical and mechanical gyroscopes and positioning Viewbix to capture a share of the projected $3.64 billion quantum‑navigation market by 2033.
Management views the patent filing as a concrete milestone that could diversify the company’s revenue streams and reduce reliance on its legacy advertising operations. The company’s strategic partnership with Quantum Gyro and the recent investment from Taurus Gold Corp. provide the financial and technical resources needed to advance the technology toward commercialization.
The announcement was met with a positive market response, reflecting investor confidence in Viewbix’s quantum‑technology strategy and the potential for the NMR gyroscope to open new revenue streams.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.